Small molecule cytokine mimetics

Chemistry and Biology

Volumn 6, Issue 4, 1999, Pages

  Whitty, Adrian ^a   Borysenko, Christopher W ^a  

^a BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033117570     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80034-9     Document Type: Review

References (42)

1. Bazan, J.F. (1990). Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl Acad. Sci. USA 87, 6934-6938.
2. Arai, K., Lee, F., Miyajima, A., Miyatake, S., Arai, N., & Yokota, T. (1990). Cytokines: Coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59, 783-836.
3. Wrighton, N.C., et al., & Dower, W.J. (1996). Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273, 458-463.
4. Cwirla, S.E., et al., & Dower, W.J. (1997). Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 276, 1696-1699.
5. Kimura, T., Kaburaki, H., Miyamoto, S., Katayama, J. & Watanabe, Y. (1997). Discovery of a novel thrombopoietin mimic agonist peptide. J. Biochem. 122, 1046-1051.
6. Tian, S.-S., et al., & Rosen, J. (1998). A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor. Science 281, 257-259.
7. Kimura, T., Kaburaki, H., Tsujino, T., Ikeda, Y., Kato, H. & Watanabe, Y. (1998). A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl. FEBS Lett. 428, 250-254.
8. Ullrich, A. & Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
9. Wells, J.A. (1994). Structural and functional basis for hormone binding and receptor oligomerization. Curr. Opin. Cell Biol. 6, 163-173.
10. Stahl, N. & Yancopoulos, G.D. (1993). The alphas, betas, and kinases of cytokine receptor complexes. Cell 74, 587-590.
11. Wells, J.A. & de Vos, A.M. (1996). Hematopoietic receptor complexes. Annu. Rev. Biochem. 65, 609-634.
12. Fuh, G., Cunningham, B.C., Fukunaga, R., Nagata, S., Goeddel, D.V. & Wells, J.A. (1992). Rational design of potent antagonists to the human growth hormone receptor. Science 256, 1677-1680.
13. Watowich, S., Yoshimura, A., Longmore, G.D., Hilton, D.J., Yoshimura, Y. & Lodish, H.F. (1992). Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl Acad. Sci. USA 89, 2140-2144.
14. Schneider, H., et al., & Giebel, L.B. (1997). Homodimerization of erythropoietin receptor by a bivalent monoclonal antibody triggers cell proliferation and differentiation of erythroid precursors. Blood 89, 473-482.
15. Young, D.C., Zhan, H., Cheng, Q.L, Hou, L. & Matthews, D.J. (1997). Characterization of the receptor binding determinants of granulocyte colony stimulating factor. Protein Sci. 6, 1228-1236.
16. Alexander, W.S., Metcalf, D. & Dunn, A.R. (1995). Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J. 14, 5569-5578.
17. Abe, M., et al. & Masuho, Y. (1998). Surrogate thrombopoietin. Immunol. Lett. 61, 73-78.
18. Deng, B. et al., & Avraham, H. (1998). An agonist murine monoclonal antibody to the human c-Mpl receptor stimulates megakaryocytopoiesis. Blood 92, 1981-1988.
19. Clackson, T., Ultsch, M.H., Wells, J.A. & de Vos, A.M. (1998). Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity. J. Mol. Biol. 277, 1111-1128.
20. Rowlinson, S.W., et al., & Waters, M.J. (1998). Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. J. Biol. Chem. 273, 5307-5314.
21. Syed, R.S., et al., & Stroud, R.M. (1998). Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395, 511-516.
22. Ballinger, M.D. & Wells, J.A. (1998). Will any dimer do? Nat. Struct. Biol. 5, 938-940.
23. Yonekura, S., Chern, Y., Donahue, K.A., Feldman, L, Vanasse, G.J. & Sytkowski, A.J. (1991). Erythropoietin receptors induced by dimethyl sulfoxide exhibit positive cooperativity associated with an amplified biologic response. Proc. Natl Acad. Sci. USA 88, 2535-2539.
24. Ilondo, M.M, Smal, J., de Meyts, P. & Courtoy, P.J. (1991). Comparison of the effects of hypertonic sucrose and intracellular potassium depletion on growth hormone receptor binding kinetics and down-regulation in IM-9 cells: Evidence for a sequential block of receptor-mediated endocytosis. Endocrinology 128, 1597-1602.
25. Pearce, K.H. Jr., Cunningham, B.C., Fuh, G., Teeri, G. & Wells, J.A. (1999). Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity. Biochemistry 38, 81 -89.
26. Kruse, N., Shen, B.-J., Arnold, S., Tony, H.-P., Muller, T. & Sebald, W. (1993). Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J. 12, 5121-5129.
27. Whitty, A., et al., & Burkly, L.C. (1998). Interaction affinity between cytokine receptor components on the cell surface. Proc. Natl Acad. Sci. USA 95, 13165-13170.
28. Nakamura, Y., et al., & Leonard, W.J. (1994.) Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domians is required for signalling. Nature 369, 330-333.
29. Walter, M.R., et al., & Narula, S.K. (1995). Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor. Nature 376, 230-235.
30. Heldin, C.-H. (1995). Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223.
31. Woodcock, J.M., McClure, B.J., Stomski, F.C., Elliott, M.J., Bagley, C.J. & Lopez, A.F. (1997). The human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor exits as a preformed receptor complex that can be activated by GM-CSF, interleukin-3, or interleukin-5. Blood 90, 3005-3017.
32. Karpusas, M., Whitty, A., Runkel, L, & Hochman, P. (1998). The structure of human interferon-β: Implications for activity. Cell. Mol. Life Sci. 54, 1203-1216.
33. Livnah, O., et al., & Wilson, I.A. (1996). Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 å. Science 273, 464-471.
34. Wrighton, N.C., et al., & Dower, W.J. (1997). Increased potency of an erythropoietin peptide mimetic through covalent dimerization. Nat. Biotechnol. 15, 1261-1265.
35. Johnson, D.L., et al., & Jolliffe, L.K. (1998). Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP-1. Biochemistry 37, 3699-3710.
36. Kimura T., Kaburaki, H., Tsujino, T., Watanabe, Y. & Kato, H. (1998). Signal transduction by the peptide which mimics the activity of thrombopoietin. Biochem. Mol. Biol. Int. 44, 1203-1209.
37. Miller, S.G. (1998). Identification of small molecule mimics of cytokines using reporter-based screens in mammalian cells. 4th Annual Conference of the Society for Biomolecular Screening, 61-73.
38. Perelson, A.S. & DeLisi, C. (1980). Receptor clustering on a cell surface. I. Theory of receptor cross-linking by ligands bearing two chemically identical functional groups. Math. Biosci. 48, 71-110.
39. Ilondo, M.M., Damholt, A.B., Cunningham, B.A., Wells, J.A., De Meyts, P., & Shymko, R.M. (1994). Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes. Endocrinology 134, 2397-2403.
40. Horan, T.P., Martin, F., Simonet, L., Arakawa, T. & Philo, J.S. (1997). Dimerization of granulocyte-colony stimulating factor receptor: The Ig plus CRH construct of granulocyte-colony stimulating factor receptor forms a 2:2 complex with a ligand. J. Biochem. 121, 370-375.
41. Dower, W.J. (1998). Targeting growth factor and cytokine receptors with recombinant peptide libraries. Curr. Opin. Chem. Biol. 2, 328-334.
42. Myszka, D.G., Arulanantham, P.R., Sana, T., Wu, Z., Morton, T.A. & Ciardelli, T.L. (1996). Kinetic analysis of ligand binding to interleukin-2 receptor complexes created on an optical biosensor surface. Protein Sci. 5, 2468-2478.